The Global Ibuprofen market will register a 5.9% CAGR in terms of revenue to reach US$ 386.3 million by 2027.
Ibuprofen is used to cure various types of diseases such as cancer, arthritis, and other chronic diseases. The growth in the number of patients suffering from these diseases is the key factor responsible to anticipate the market rise in the forecasted period. Further, the growing population along with the heavy burden of an aging population and the easy availability of such NSAID category drugs is expected to create a huge demand for the market. Moreover, ibuprofen is an effective antipyretic and analgesic in infants. This is considered safe for children and infants younger than six months. Ibuprofen is useful to cure mild fever, gastrointestinal pain, dental pain, and others for a short period. This is further used to cure patent ductus in premature babies. As a result, the rising in the younger population and utilization of this safe drug to treat mild symptoms is expected to boost the growth of the market. Further, the availability of ibuprofen in wide forms of tablets, capsule powder, and syrups at a very economical price has propelled the rising of the global ibuprofen market. However, adverse side effects associated with the consumption of ibuprofen drugs can restrain the rise of the global ibuprofen market.
The global Ibuprofen includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Xinhua-Perrigo Pharmaceutical, Hisoar and others. and others.
Industry News
With its newest invention, ibuprofen in an IV bag, Cumberland Pharmaceuticals company may be able to reduce opioid use.
In 2020, A Cumberland Pharmaceuticals company launched a new form of injectable ibuprofen on Tuesday, which researchers say has the potential to drastically reduce the use of opioid painkillers in hospitals and prevent addictions from starting.
It has 30,000 doses of its new product, Caldolor in ready-to-use intravenous bags, ready for sale, according to CEO A.J. Kazimi. According to Kazimi, the company expects to sell hundreds of thousands of ibuprofen bags by the end of the year.
Arthritis Holds Significant Share in the Global Ibuprofen API Market
Arthritis refers to the inflammation of a joint. When joints are inflamed, they can develop stiffness, warmth, swelling, redness and pain. There are over 100 types of arthritis, namely osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus, gout, pseudogout, etc. Rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints of the body. Rheumatoid arthritis disease mostly affects the joints of the hand, wrists, elbows, knees, and ankles.
Higher doses of ibuprofen are available on prescription and can be used if one has rheumatoid arthritis or another type of inflammatory arthritis. In doses of 1,200 mg/day or more, ibuprofen is as effective as aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of rheumatoid arthritis. The tolerability and safety of ibuprofen are superior to those of aspirin and compare favorably with those of other NSAIDs.
Ibuprofen Market is segmented based on the type, applications, companies and regions
By Type, it is segmented into
By Applications, it is segmented into
Asia-Pacific is expected to Witness High Growth Rate the Global Ibuprofen API Market
The Asia-Pacific market is anticipated to witness high growth during the forecast period, due to increasing healthcare expenditure. Additionally, the low cost of manufacturing in China and India has resulted in the rise in the production facilities, attracting pharmaceutical and biotechnological giants to the Asia-Pacific region from across the world.
The increase in the incidence of rheumatoid arthritis disease is also expected to propel the market in the region during the forecast period. For example, according to the Institute for Health Metrics and Evaluation, the number of cases of rheumatoid arthritis has increased from 183,272 to 263,365 in India. Therefore, analyzing the number of cases in other major countries of the Asia Pacific region, the healthcare activities in relation to the treatment of rheumatoid arthritis would require large and continuous support from everyone. China is the largest supplier of ibuprofen, accounting for nearly 48 percent of the global production market. India is the world's second-largest supplier of ibuprofen, with a production market share of nearly 30%.
With a sales market share of nearly 29 percent, North America is the largest sales region. Following North America, Europe is the second-largest sales region, with a 26 percent sales market share.
North America
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 13.4% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Xinhua-Perrigo Pharmaceutical, Hisoar and others. | |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 93 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Ibuprofen Market is studied from 2017 - 2027.
What is the growth rate of Ibuprofen Market?
The Ibuprofen Market is growing at a CAGR of 13.4% over the next 5 years.
What regions does this Ibuprofen Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.